Multi-Component Breath Alcohol Intervention Phase 3

Launched by NORTHEASTERN UNIVERSITY · May 20, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help young adults who drink heavily to manage their alcohol consumption. It involves a combination of brief online counseling and the use of mobile apps that provide personalized feedback about their blood or breath alcohol levels. The goal is to see if these tools can help participants drink in moderation. The trial is currently recruiting participants aged 18 to 25 who have recently engaged in heavy drinking, meaning women who have had 4 or more drinks and men who have had 5 or more drinks in a single occasion in the past month.

If you or someone you know is eligible, participants will use these technologies during the study period and share their experiences regarding how easy they are to use and how helpful they find them. It's important to note that individuals with severe substance use disorders, certain psychiatric conditions, or specific medical issues that make drinking unsafe are not eligible to participate. This trial is a chance to contribute to important research aimed at reducing heavy drinking among young adults.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Be between the ages of 18-25
• • Be able to read English and complete study evaluations
• • At least occasional heavy episodic drinking (i.e., 4 or more drinks for women and 5 or more drinks for men) over the prior 30 days
• • Frequent consumption of at least one alcoholic drink during a minimum of 12 days out of the prior 30 so that subjects will have multiple opportunities to use the moderate drinking technologies during the intervention period.
• Exclusion Criteria:
• • Severe substance use disorder
• • Be psychotic or otherwise severely psychiatrically disabled
• • Report a history of a medical condition that would contraindicate the consumption of alcohol (e.g., liver disease, cardiac abnormality, pancreatitis, diabetes, neurological problems, and gastrointestinal disorders)